Christopher J. Weir

Adaptive designs in clinical trials: why use them, and how to run and report them

Philip Pallmann, Alun Bedding, Babak Choodari‐Oskooei et al. · BMC Medicine · 2018 · 764 citations · Full text

Is hyperglycaemia an independent predictor of poor outcome after acute stroke? Results of a long term follow up study

Christopher J. Weir, Gordon Murray, Alexander Dyker et al. · BMJ · 1997 · 527 citations

Comparison of Neurological Scales and Scoring Systems for Acute Stroke Prognosis

Keith W. Muir, Christopher J. Weir, Gordon Murray et al. · Stroke · 1996 · 443 citations

High-sensitivity troponin in the evaluation of patients with suspected acute coronary syndrome: a stepped-wedge, cluster-randomised controlled trial

Anoop Shah, Atul Anand, Fiona E. Strachan et al. · The Lancet · 2018 · 371 citations · Full text

Intravenous ferric derisomaltose in patients with heart failure and iron deficiency in the UK (IRONMAN): an investigator-initiated, prospective, randomised, open-label, blinded-endpoint trial

Paul R. Kalra, John G.F. Cleland, Mark C. Petrie et al. · The Lancet · 2022 · 344 citations · Full text

Heart Failure, Intravenous Ferric Derisomaltose, Iron Metabolism +3